Sign In

William Fahl

Professor of Oncology, University of Wisconsin

William Fahl is a Professor of Oncology at the University of Wisconsin-Madison and a member of the Cancer Control Program at the UW Carbone Cancer Center.12 He received his BS in Zoology/Chemistry in 1972 and his PhD in Physiology/Oncology in 1975, both from the University of Wisconsin-Madison.1

Dr. Fahl's research focuses on enabling cells to protect their genomes against toxic molecules encountered during various conditions, including cancer therapy, normal oxidative life, organ transplantation, heart attacks, and exposure to ionizing radiation.1 His laboratory approaches this goal through two main strategies:

  1. Developing protective drug molecules for topical application to at-risk epithelial cells in cancer therapy patients.
  2. Inventing and synthesizing a new reactive oxygen species (ROS) scavenger called PrC-210 for systemic administration in various medical scenarios.

His work has led to clinical trials and the development of potential drugs to prevent or suppress side effects of cancer treatments, such as oral mucositis, radiation dermatitis, and alopecia.1 Dr. Fahl's research has resulted in several US and PCT patents, and he is involved in the commercial development of these drug formulations through companies like NG Biomedicine.1

Highlights

Sep 1 · mcardle.wisc.edu
McArdle Faculty
McArdle Faculty

Related Questions

What are the main focuses of William Fahl's research?
How has William Fahl's work impacted cancer therapy?
What are the key findings from William Fahl's clinical trials?
How does William Fahl's research contribute to the field of oncology?
What are the potential applications of PrC-210 in medical settings?
W
Add to my network

Location

Madison, Wisconsin, United States